Perbedaan Budi Starch Sweetener Tbk dan Cipta Sarana Medika Tbk.: Budi Starch Sweetener Tbk diperdagangkan di Rp220 (kapitalisasi pasar 980,78 M, volume 24 jam 478 rb), sedangkan Cipta Sarana Medika Tbk. diperdagangkan di Rp64 (kapitalisasi pasar 160,67 M, volume 24 jam 13,88 jt). Perbedaan utamanya: Budi Starch Sweetener Tbk jauh lebih besar — sekitar 6,1× kapitalisasi pasar Cipta Sarana Medika Tbk., dan Cipta Sarana Medika Tbk. lebih aktif diperdagangkan (13,88 jt vs 478 rb). Mana yang lebih baik tergantung tujuan investasimu.
| BUDI | DKHH | |
|---|---|---|
Kapitalisasi Pasar | 980,78 M | 160,67 M |
Volume | 478 rb | 13,88 jt |
Lot | 4,78 rb | 138,82 rb |
Perputaran | 106,03 jt | 889 jt |
Harga Rata-rata | 221,82 | 64,04 |
Nilai Transaksi | 106,03 jt | 889 jt |
Harga Ekuilibrium Indikatif | 224 | 63 |
Volume Ekuilibrium Indikatif | 12 | 4,8 rb |
Imbal hasil berjalan pada periode standar
Berita terbaru kedua aset
PT Budi Starch & Sweetener Tbk (the Company) formerly Budi Acid Jaya (BAJ) was established based on Notarial Deed No. 15 dated January 15, 1979 of Henk Limanow, SH., public notary in Jakarta. PT Budi Starch & Sweetener Tbk is the world`s largest tapioca starch producer. BAJ is an integrated cassava based manufacturer : citric acid, modified tapioca starch and monosodium glutamate (MSG). It also produces sulphuric acid and poly propelene woven bag.
Selengkapnya di halaman BUDI →PT Cipta Sarana Medika Tbk (the Company) was established based on Deed No. 90 dated September 17, 2014 by Dede Fujianti, SH., M.Kn., Notary in Sukabumi. The Company ultimate parent entity is PT Siliwangi Djajakusumah Bersatu. The Company started its commercial operations in 2014.
Selengkapnya di halaman DKHH →